- Published
- 02 October 2020
- Journal article
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days
- Authors
-
- Source
- F1000 Research
Abstract
Rights
Copyright: © 2020 Janiaud P et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite as
Janiaud, P., Axfors, C., Van't Hooft, J., Saccilotto, R., Agarwal, A., Appenzeller-Herzog, C., Contopoulos-Ioannidis, D., Danchev, V., Dirnagl, U., Ewald, H., Gartlehner, G., Goodman, S., Haber, N., Ioannidis, A., Ioannidis, J., Lythgoe, M., Ma, W., MacLeod, M., Malički, M., Meerpohl, J., Min, Y., Moher, D., Nagavci, B., Naudet, F., Pauli-Magnus, C., O'Sullivan, J., Riedel, N., Roth, J., Sauermann, M., Schandelmaier, S., Schmitt, A., Speich, B., Williamson, P. & Hemkens, L. 2020, 'The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days', F1000 Research, 9(1193). https://doi.org/10.12688/f1000research.26707.1